EDGAR·FLOW

ALX ONCOLOGY HOLDINGS INC — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 1/100
What the filing says
Filing header received for ALX Oncology Q3 2026 10-Q (period ended 9/30/2026), filed 11/16/2026. Full document text required to extract financial metrics, operational changes, cash position, clinical updates, or material events. At $18M market cap, nearly any material development is significant.
Why this rating

Cannot score without actual 10-Q disclosures. Request full document body.

View original filing on SEC.gov ↗ ALXO · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.